… not expressing PDL-1.Ethics Approval The study was approved by The University of Sydney Ethics Board, approval number X18-0525 & 2019/ETH08954.Abstract 40 Figure 1K…
All extracted funders
Showing 601–660 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
Articles mentioning funders
5,089 articles · page 329 of 425…of ICON plc (Blue Bell, PA, USA). This assistance was funded by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.References …
…e (Buddy Charbono and Andy Vasquez). This work was supported by The NIH Shared Instrumentation Grant S10OD032325 for the Cytek Aurora housed in the Flow Cytometry Core at Sanfo…
…immunotherapeutic. The IND application was approved by both the FDA and NMPA, and Phase I trials were initiated in Q2 2025, offerin…
…c efficacy of immunotherapy.Ethics Approval Ethics committee of AbbVie gave ethical approval for this work.…
…t immunotherapy efficacy in GBM.Acknowledgements We acknowledge TME Pharma AG for providing of Nox-A12References De Filippo K, Rankin SM, CXC…
… Center (University of California Irvine). S.G. is supported by NIH T32 AI177324 and an NSF-GRFP fellowship 2235784.References Wolchok JD, et al…
…h was a collaborative effort made possible through support from F. Hoffmann-La Roche Ltd.Ethics Approval The protocol was approved by the institutional …
…small cell lung cancer (NSCLC) in a Phase I/II clinical trial ( NCT04995523).1 Rilvegostomig is currently progressing through multiple Phas…
…Lab Fellowship), the Swedish Research Council (2022-01461), the Swedish Foundation for Strategic Research (FFL-0043), and the Swedish Cancer Society (220474JIA; 232656Pj…
… of care chemotherapy.Acknowledgements Funding was supported by Teclison, Inc.Trial Registration NCT03259867, NCT04701476Ethics Approval Ethic…
…noma is underway.Trial Registration The study was registered at ClinicalTrials.gov ( NCT04117087).Ethics Approval The study protocol and all amend…